Your browser doesn't support javascript.
loading
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier, Patricia; Floquet, Anne; Chevreau, Christine; Penel, Nicolas; Guillemet, Cécile; Delcambre, Corinne; Cupissol, Didier; Selle, Frédéric; Isambert, Nicolas; Piperno-Neumann, Sophie; Thyss, Antoine; Bertucci, François; Bompas, Emmanuelle; Alexandre, Jerôme; Collard, Olivier; Lavau-Denes, Sandrine; Soulié, Patrick; Toulmonde, Maud; Le Cesne, Axel; Lacas, Benjamin; Duffaud, Florence.
Afiliação
  • Pautier P; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. Electronic address: patricia.pautier@gustaveroussy.fr.
  • Floquet A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Chevreau C; Department of Medical Oncology, Institut Claudius-Regaud, Toulouse, France.
  • Penel N; Department of Medical Oncology, Centre Oscar-Lambret, Lille, France.
  • Guillemet C; Department of Medical Oncology, Centre Henri-Becquerel, Rouen, France.
  • Delcambre C; Department of Medical Oncology, Centre François-Baclesse, Caen, France.
  • Cupissol D; Department of Medical Oncology, Centre Val d'Aurelle, Montpellier, France.
  • Selle F; Department of Medical Oncology, Hôpital Tenon, Paris, France.
  • Isambert N; Department of Medical Oncology, Centre GF Leclerc, Dijon, France.
  • Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.
  • Thyss A; Department of Medical Oncology Centre Antoine Lacassagne, Nice, France.
  • Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Bompas E; Department of Medical Oncology, Centre René Gauducheau, Saint Herblain, France.
  • Alexandre J; Department of Medical Oncology, Hôpital Cochin, Paris, France.
  • Collard O; Department of Medical Oncology, Institut de Cancérologie de la Loire, Saint Priest en Jarez, France.
  • Lavau-Denes S; Department of Medical Oncology, Centre Hospitalo-Universitaire Dupuytren, Limoges, France.
  • Soulié P; Department of Medical Oncology, Centre Paul Papin, Angers, France.
  • Toulmonde M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Le Cesne A; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Lacas B; Department of Biostatistics, Institut Gustave Roussy, Villejuif, France.
  • Duffaud F; Department of Medical Oncology, La Timone University Hospital, Marseille, France.
Lancet Oncol ; 16(4): 457-64, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25795402
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Tecidos Moles / Neoplasias Uterinas / Doxorrubicina / Tetra-Hidroisoquinolinas / Dioxóis / Leiomiossarcoma Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Tecidos Moles / Neoplasias Uterinas / Doxorrubicina / Tetra-Hidroisoquinolinas / Dioxóis / Leiomiossarcoma Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article